We came across a fascinating study showing refractory angina patients undergoing Enhanced External Counterpulsation (EECP®) therapy to experience lower levels of chest pain and higher levels of confidence and self-efficacy. This thesis research by R. Foxwell also finds the patients less afraid of dying – a surprising discovery.
“Not only did (EECP) push me to do it, but also by doing it, it showed me that I don’t need to worry so much about it for the future, so since I’ve come back I’m pushing myself that much more all the time, which is good,” said one of the patients after undergoing the therapy.
We know that EECP stimulates collateral formation—the growth of new blood vessels—that increases blood flow to the heart, having effects similar to exercise. This thesis confirmed the belief that EECP Therapy reduces the effects of angina, which leads to a more optimistic view of the condition by the patient population, creating a positive cycle of physiological and psychological wellbeing.
The study also finds EECP to have an overall reduction of healthcare expenses. Patients undergoing EECP therapy require less-frequent visits to general practitioners and less medication compared with the period before EECP Therapy.
Such findings motivates everyone here at Vasomedical to push harder to make sure all refractory angina patients learn and have access to EECP® Therapy!
*The study is a dissertation submitted in partial fulfillment of the requirements for the Degree of Doctor of Clinical Psychology in the University of Hull, United Kingdom by Rachel Foxwell, BSc in Psychology, entitled: “Psychosocial Outcomes of Enhanced External Counterpulsation Treatment: Illness Perceptions and Psychological Wellbeing”.